<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="pmc-domain-id">440</journal-id><journal-id journal-id-type="pmc-domain">plosone</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>PLOS</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC5908182</article-id><article-id pub-id-type="pmcid-ver">PMC5908182.1</article-id><article-id pub-id-type="pmcaid">5908182</article-id><article-id pub-id-type="pmcaiid">5908182</article-id><article-id pub-id-type="pmid">29672606</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0193664</article-id><article-id pub-id-type="publisher-id">PONE-D-17-38041</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Bioenergetics</subject><subj-group><subject>Energy-Producing Organelles</subject><subj-group><subject>Mitochondria</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Cellular Structures and Organelles</subject><subj-group><subject>Energy-Producing Organelles</subject><subj-group><subject>Mitochondria</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Developmental Biology</subject><subj-group><subject>Cell Differentiation</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Cellular Types</subject><subj-group><subject>Animal Cells</subject><subj-group><subject>Hepatocytes</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Liver</subject><subj-group><subject>Hepatocytes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Liver</subject><subj-group><subject>Hepatocytes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical Compounds</subject><subj-group><subject>Ammonia</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Metabolism</subject><subj-group><subject>Energy Metabolism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Processes</subject><subj-group><subject>Energy Metabolism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Processes</subject><subj-group><subject>Energy Metabolism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical Compounds</subject><subj-group><subject>Organic Compounds</subject><subj-group><subject>Urea</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Organic Chemistry</subject><subj-group><subject>Organic Compounds</subject><subj-group><subject>Urea</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Bile</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Bile</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Bile</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Bile</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Cellular Types</subject><subj-group><subject>Animal Cells</subject><subj-group><subject>Stem Cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>A practice-changing culture method relying on shaking substantially increases mitochondrial energy metabolism and functionality of human liver cell lines</article-title><alt-title alt-title-type="running-head">Shaking increases mitochondrial energy metabolism and functionality of human liver cell line cultures</alt-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Adam</surname><given-names initials="AAA">Aziza A. A.</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing &#8211; original draft</role><role content-type="http://credit.casrai.org/">Writing &#8211; review &amp; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>van der Mark</surname><given-names initials="VA">Vincent A.</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Writing &#8211; original draft</role><role content-type="http://credit.casrai.org/">Writing &#8211; review &amp; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Donkers</surname><given-names initials="JM">Joanne M.</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing &#8211; original draft</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wildenberg</surname><given-names initials="ME">Manon E.</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing &#8211; original draft</role><role content-type="http://credit.casrai.org/">Writing &#8211; review &amp; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Oude Elferink</surname><given-names initials="RPJ">Ronald P. J.</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#8211; original draft</role><role content-type="http://credit.casrai.org/">Writing &#8211; review &amp; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chamuleau</surname><given-names initials="RAFM">Robert A. F. M.</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#8211; original draft</role><role content-type="http://credit.casrai.org/">Writing &#8211; review &amp; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-7325-2394</contrib-id><name name-style="western"><surname>Hoekstra</surname><given-names initials="R">Ruurdtje</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#8211; original draft</role><role content-type="http://credit.casrai.org/">Writing &#8211; review &amp; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Tytgat Institute for Liver and Intestinal Research, Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Experimental Surgical Laboratory, Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Department Of Gastroenterology and Hepatology, Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands</addr-line></aff><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Pazienza</surname><given-names initials="V">Valerio</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Ospedale Casa Sollievo della Sofferenza, ITALY</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>RAFMC is Chief Scientific Officer of the university spin-off company Hep-Art Medical Devices B.V that holds the exclusive license to the AMC-Bioartificial liver. RH was previously employed part-time by Hep-Art Medical Devices B.V. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. This does not alter our adherence to PLOS ONE policies on sharing data and materials.</p></fn><corresp id="cor001">* E-mail: <email>r.hoekstra@amc.uva.nl</email></corresp></author-notes><pub-date pub-type="epub"><day>19</day><month>4</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>13</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">309582</issue-id><elocation-id>e0193664</elocation-id><history><date date-type="received"><day>25</day><month>10</month><year>2017</year></date><date date-type="accepted"><day>15</day><month>2</month><year>2018</year></date></history><pub-history><event event-type="pmc-release"><date><day>19</day><month>04</month><year>2018</year></date></event><event event-type="pmc-live"><date><day>06</day><month>05</month><year>2018</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-07-20 03:25:13.120"><day>20</day><month>07</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2018 Adam et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Adam et al</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="pone.0193664.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="pone.0193664.pdf"/><abstract><p>Practice-changing culturing techniques of hepatocytes are highly required to increase their differentiation. Previously, we found that human liver cell lines HepaRG and C3A acquire higher functionality and increased mitochondrial biogenesis when cultured in the AMC-Bioartificial liver (BAL). Dynamic medium flow (DMF) is one of the major contributors to this stimulatory effect. Recently, we found that DMF-culturing by shaking of HepaRG monolayers resulted in higher mitochondrial biogenesis. Here we further investigated the effect of DMF-culturing on energy metabolism and hepatic functionality of HepaRG and C3A monolayers. HepaRG and C3A DMF-monolayers were incubated with orbital shaking at 60 rpm during the differentiation phase, while control monolayers were maintained statically. Subsequently, energy metabolism and hepatic functionality were compared between static and DMF-cultures. DMF-culturing of HepaRG cells substantially increased hepatic differentiation; transcript levels of hepatic structural genes and hepatic transcription regulators were increased up to 15-fold (Cytochrome P450 3A4) and nuclear translocation of hepatic transcription factor CEBP&#945; was stimulated. Accordingly, hepatic functions were positively affected, including ammonia elimination, urea production, bile acid production, and CYP3A4 activity. DMF-culturing shifted energy metabolism from aerobic glycolysis towards oxidative phosphorylation, as indicated by a decline in lactate production and glucose consumption, and an increase in oxygen consumption. Similarly, DMF-culturing increased mitochondrial energy metabolism and hepatic functionality of C3A cells. In conclusion, simple shaking of monolayer cultures substantially improves mitochondrial energy metabolism and hepatic differentiation of human liver cell lines. This practice-changing culture method may prove to prolong the <italic toggle="yes">in-vitro</italic> maintenance of primary hepatocytes and increase hepatic differentiation of stem cells.</p></abstract><funding-group><award-group id="award001"><funding-source><institution>EU</institution></funding-source><award-id>n304914</award-id><principal-award-recipient><name name-style="western"><surname>Chamuleau</surname><given-names>Robert A. F. M.</given-names></name></principal-award-recipient></award-group><award-group id="award002"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001826</institution-id><institution>ZONMW</institution></institution-wrap></funding-source><award-id>114021009</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-7325-2394</contrib-id><name name-style="western"><surname>Hoekstra</surname><given-names>Ruurdtje</given-names></name></principal-award-recipient></award-group><funding-statement>The research leading to these results has received funding from the European Community&#8217;s Seventh Framework Programme FP7/2007-2013 under grant agreement n304914 to RAFMC, and from the Netherlands Organisation for Health Research and Development, More Knowledge with Fewer Animals, grant 114021009 to RH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="6"/><table-count count="0"/><page-count count="19"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Highly differentiated human hepatocytes from proliferative sources are needed to serve as predictive hepatocyte model <italic toggle="yes">in vitro</italic> and as biocomponent for Bio-Artificial Livers (BALs). However, to date, hepatocytes deriving from different proliferative sources, as stem cells, induced pluripotent stem cells and liver cell lines, are deficient in complex hepatic functions [<xref rid="pone.0193664.ref001" ref-type="bibr">1</xref>].</p><p>HepaRG is the human liver progenitor cell line increasingly used as human liver model for the prediction of hepatotoxicity and human liver infections, and is also applied as biocomponent in the AMC-Bio-Artificial liver (AMC-BAL), [<xref rid="pone.0193664.ref002" ref-type="bibr">2</xref>&#8211;<xref rid="pone.0193664.ref004" ref-type="bibr">4</xref>] as the functionality is relatively high, and its transcriptome closely resembles that of primary human hepatocytes [<xref rid="pone.0193664.ref005" ref-type="bibr">5</xref>]. HepaRG cultures develop during 28 days into a mixed heterogeneous culture with hepatocyte-islands and bile duct-like cells. Treating HepaRG cells with 2% dimethylsulfoxide (DMSO) during the last two weeks of culturing, enhances their hepatic differentiation and the detoxification properties, however, it also increases cell damage [<xref rid="pone.0193664.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0193664.ref006" ref-type="bibr">6</xref>]. Interestingly, HepaRG cells cultured in the AMC-BAL platform have increased hepatic functionality and integrity compared to HepaRG monolayer cultures [<xref rid="pone.0193664.ref007" ref-type="bibr">7</xref>]. Of particular interest, BAL-cultured HepaRG cells efficiently eliminate lactate, while monolayer-cultured cells produce lactate [<xref rid="pone.0193664.ref008" ref-type="bibr">8</xref>&#8211;<xref rid="pone.0193664.ref010" ref-type="bibr">10</xref>]. Lactate elimination is a hallmark function of highly differentiated hepatocytes, and is lacking in the available hepatocyte culture models. Consistent with this, we recently found that BAL-culturing enhances mitochondrial biogenesis and mitochondrial activity, resulting in a shift of energy metabolism towards oxidative phosphorylation (OxPhos) [<xref rid="pone.0193664.ref011" ref-type="bibr">11</xref>].The stimulatory effect of the AMC-BAL culture on mitochondrial biogenesis also applied to another human liver cell line, C3A, a sub-clone of the HepG2 hepatoma cell line [<xref rid="pone.0193664.ref012" ref-type="bibr">12</xref>]. Among the driving factors underlying this metabolic shift is the presence of dynamic medium flow (DMF) in the BAL system [<xref rid="pone.0193664.ref013" ref-type="bibr">13</xref>]. We mimicked the DMF of the BAL by placing monolayer cultures into a shaking incubator (at 60 rpm) during the differentiation phase. Culturing of HepaRG monolayers with DMF increased their mitochondrial abundance 3.3- fold and the expression levels of mitochondrial inner membrane OxPhos complexes [<xref rid="pone.0193664.ref011" ref-type="bibr">11</xref>]. Recent studies reported a strong, likely causal, relationship between mitochondrial energy metabolism and differentiation of stem cells. On one hand, inhibition of OxPhos augments the expression of pluripotency markers in stem cells [<xref rid="pone.0193664.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0193664.ref015" ref-type="bibr">15</xref>]. On the other hand, increased mitochondrial biogenesis with a shift in cellular energy metabolism towards Oxphos is associated with the differentiation of stem cells, <italic toggle="yes">e</italic>.<italic toggle="yes">g</italic>. into hepatocyte-like cells [<xref rid="pone.0193664.ref016" ref-type="bibr">16</xref>].</p><p>In the current work, we investigated whether the increased mitochondrial biogenesis in HepaRG DMF-monolayers is also positively associated with hepatic functionality, and extended the study for cell line C3A.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Material and methods</title><sec id="sec003"><title>Cell culture</title><p>HepaRG cells were kindly provided by Biopredic International (Rennes, France). HepaRG cells and C3A cells (ATCC&#174; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="CRL10741">CRL10741</ext-link>&#8482;) were maintained in HepaRG medium, as described [<xref rid="pone.0193664.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0193664.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0193664.ref010" ref-type="bibr">10</xref>]. For testing, the HepaRG and C3A cells were seeded in 12-well culture plates (Corning, Corning, USA), unless indicated otherwise, and cultured under either Static or DMF-regimen. The Static groups were cultured under conventional conditions, <italic toggle="yes">i</italic>.<italic toggle="yes">e</italic>. static in a humidified atmosphere of 95% air and 5% CO<sub>2</sub>. One group was supplemented with 2% DMSO for the last two weeks of culturing (HepaRG-DMSO-Static), and the other was maintained without DMSO (HepaRG-Static).The DMF-group was kept for an initial phase (proliferation phase) under conventional conditions, being14 days for HepaRG and 3 days for C3A cells, followed by a 14 days (HepaRG cells) or 11 days (C3A cells) shaking-phase under the same atmosphere in a shaking incubator (Eppendorf, Westbury, USA) with 60 rpm orbital-shaking frequency. Three days prior testing, the cultures were supplemented with 1 mM carbamoyl-glutamate (CAG) (Sigma-Aldrich, St. Louis, USA) to stimulate carbamoyl phosphate synthetase 1 (CPS1) activity [<xref rid="pone.0193664.ref006" ref-type="bibr">6</xref>]. All cultures were maintained at 37&#176;C and were negative for mycoplasma.</p></sec><sec id="sec004"><title>Hepatic function test</title><p>The cultures were tested for their functionality, as described [<xref rid="pone.0193664.ref009" ref-type="bibr">9</xref>]. Briefly, monolayer cultures were exposed to 1.5 ml test medium, based on HepaRG medium supplemented with 1 mM CAG, 1.5 mM NH<sub>4</sub>Cl, 2.27 mM D-galactose, 2 mM L-lactate and 125 &#956;M testosterone (all compounds from Sigma-Aldrich). During the function test, medium samples were taken at 45 min (0.5 mL) and at 24 h (1 ml), in which L-lactate, ammonia, urea, glucose, bile acid and human albumin concentrations were measured. L-lactate determination was performed using L-lactic acid assay kit (Megazyme, Wicklow, Ireland). Ammonia was assessed using Ammonia assay kit (Megazyme). Urea production was measured according to the blood urea nitrogen protocol (Sigma). Glucose concentration was determined with a glucosemeter (Contour&#174; next) (Bayer, Leverkusen, Germany). In addition, total bile acid concentration was determined using the DIAZYME total bile acid assay kit (DIAZYME Laboratories, Dresden, Germany). Human albumin was measured using the Human Serum Albumin DuoSet ELISA according to supplier&#8217;s instructions (R&amp;D systems Inc., Minneapolis, USA).</p><p>Metabolic rates were determined by calculating the changes in concentration in medium in time and then normalized to the protein content per well. The cultures were also tested for baseline and induced CYP3A4 activity using the P450-Glo&#8482; CYP3A4 (Luciferin-IPA) Assay kit (Promega, Madison, USA). CYP3A4 activity was optionally induced by a 3-day treatment with 10 &#956;M rifampicin (Sigma-Aldrich) prior to testing. The measured CYP3A4 activity, expressed as Relative Luminescence Units (RLU), was normalized to protein content per well. Total protein concentration was determined using the Bio-Rad protein assay (Bio-Rad, Irvine, USA), according to manufacturer&#8217;s protocol.</p></sec><sec id="sec005"><title>Oxygen consumption determination</title><p>HepaRG-Static and DMF-cultures were fully differentiated in 24-well culture plates (OxoDish&#174;, PreSens, Regensburg, Germany) with oxygen sensor spots at the bottom of the well. Pericellular oxygen concentrations were measured through the bottom of the culture plates using the SDR SensorDish&#174; Reader, which was kindly made available by Applikon Biotechnology, Delft, the Netherlands. The measured oxygen consumption was normalized to protein content per well.</p></sec><sec id="sec006"><title>Quantitative reverse transcription-polymerase chain reaction (qRT-PCR)</title><p>Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany), and qRT-PCR was performed as described [<xref rid="pone.0193664.ref009" ref-type="bibr">9</xref>]. Transcript levels were normalized for 18S ribosomal RNA. Primer sequences and amplicon sizes are given in <xref ref-type="supplementary-material" rid="pone.0193664.s001">S1 Table</xref>. Transcript levels of Static and DMF- cultures of HepaRG and C3A were expressed as a % of the average of two human healthy liver samples of two female patients aged 40 and 41 years undergoing liver resection, in <xref ref-type="supplementary-material" rid="pone.0193664.s002">S2 Table</xref> and <xref ref-type="supplementary-material" rid="pone.0193664.s003">S3 Table</xref> respectively.</p></sec><sec id="sec007"><title>Taurocholate uptake assay</title><p>Taurocholate (TC) uptake was measured as described [<xref rid="pone.0193664.ref017" ref-type="bibr">17</xref>], using chemicals from Merck (Darmstadt, Germany), unless indicated otherwise. The cultures were washed twice with uptake buffer (5 mM KCl, 1.1 mM K<sub>2</sub>HPO4, 1 mM MgCl<sub>2</sub> (Sigma-Aldrich) 1.8 mM CaCl<sub>2</sub>, 10 mM D-Glucose, 10 mM HEPES, 136 mM NaCl, pH 7.4), and then exposed to 500 &#956;L uptake buffer containing 10 &#956;M <sup>3</sup>H-labelled TC (PerkinElmer, Waltham, USA) for 2 min at 37&#176;C. Subsequently, the cells were washed 4x with ice-cold PBS and lysed in 0.05% SDS for 30 min at room temperature. Radioactivity was measured by liquid scintillation counting using the TRI-CARB 2900 TR (PerkinElmer) and data was normalized to protein content per well.</p></sec><sec id="sec008"><title>Immunofluorescence staining</title><p>Cultures in 6-well plates were fixed with 2% formalin (VWR, Radnor, USA) for 2&#8211;5 min at room temperature prior to permeabilization with 0.3% Triton-X100 (Bio-Rad) in cold PBS, for 20 min on ice. The monolayers were blocked for 1h with 10% fetal calf serum (BioWhittaker, Walkersville, USA) in PBS on ice before overnight incubation with the primary antibody diluted 1:200 in PBS at 4&#176;C. Cultures were washed 3x with cold PBS, incubated 2h at 4&#176;C with secondary fluorescent antibody diluted 1:1000 in PBS, then washed 3x with cold PBS before incubation with DAPI-containing Vectashield (Vector Laboratories, Burlingame, USA). Imaging was performed with a DM6000B fluorescent microscope (Leica Microsystems, Wetzlar, Germany) and images were processed using ImageJ software (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://imagej.nih.gov/ij/">http://imagej.nih.gov/ij/</ext-link>).</p><p>Primary antibodies: Goat anti-human albumin (Bethyl Laboratories, Montgomery, USA), Rabbit anti-human SOX9 (Millipore, Billerica, USA), Goat anti-human CEBPa (Santa-Cruz, Dallas, USA), Rabbit anti-rat OATP1a1 (Alpha Diagnostics, San Antonio, USA), Mouse anti-human MRP2 (Enzo Life Sciences, Oyster Bay, USA).</p><p>Fluorescent secondary antibodies were obtained from Invitrogen, unless indicated: Donkey anti-rabbit/Alexa Flour-546, Donkey anti-goat/Alexa Flour-448 (Molecular Probes, Eugene, USA), Donkey anti-goat/Alexa Flour-546, Goat anti-rabbit/Alex Flour-448, Goat anti-mouse/Alexa Flour-546.</p></sec><sec id="sec009"><title>Cellular polarization assay</title><p>To assess cellular polarization, the cultures were incubated with 20 &#956;M 5-carboxyfluorescein diacetate (CFDA; Molecular Probes, Eugene, USA) in PBS at 37&#176;C for 15 min to allow its internalization and subsequent translocation into the canalicular lumen by the multidrug resistance protein 2 (MRP2) ATP-binding cassette transporter. Then the cultures were washed 2x with PBS and mounted with DAPI containing Vectashield. Imaging was performed with fluorescent microscope (Leica Microsystems).</p></sec><sec id="sec010"><title>Statistical analyses</title><p>Statistical analyses were performed in Prism version 7 (GraphPad Prism Inc. San Diego, USA) using Student&#8217;s <italic toggle="yes">t</italic>-tests for the comparison between two groups.</p></sec></sec><sec sec-type="results" id="sec011"><title>Results</title><sec id="sec012"><title>DMF-culturing enhances HepaRG cell differentiation</title><p>We assessed whether DMF-culturing increased the hepatic differentiation of HepaRG cells compared to conventional static culturing by co-staining of two markers; albumin (ALB), as a marker of differentiated hepatocytes, and Sry (sex determining region Y)-box 9 (SOX9), as a progenitor cell marker. SOX9 is a transcription factor, highly expressed in pluripotent, fetal, and adult stem and progenitor cells that maintains their undifferentiated-status [<xref rid="pone.0193664.ref018" ref-type="bibr">18</xref>, <xref rid="pone.0193664.ref019" ref-type="bibr">19</xref>]. HepaRG-DMF cultures exhibited decreased SOX9 expression compared to HepaRG-Static cultures (<xref ref-type="fig" rid="pone.0193664.g001">Fig 1A</xref> and <xref ref-type="supplementary-material" rid="pone.0193664.s005">S1 Fig</xref> for higher resolution). In addition, HepaRG-Static cultures showed predominant SOX9 nuclear translocation, which was less prominent in HepaRG-DMF cultures. Furthermore, the expression of SOX9 was also studied in HepaRG-Static controls supplemented with 2% DMSO (HepaRG-DMSO-Static). Similarly, the expression of SOX9 was clearly reduced in HepaRG-DMSO-Static cultures compared to HepaRG-Static (<xref ref-type="supplementary-material" rid="pone.0193664.s005">S1 Fig</xref>). The expression of albumin was confined to hepatocyte islands and was not different between Static and DMF-cultures (<xref ref-type="fig" rid="pone.0193664.g001">Fig 1A</xref> and <xref ref-type="supplementary-material" rid="pone.0193664.s005">S1 Fig</xref>). In line with this, human albumin synthesis measured by ELISA was comparable in HepaRG-DMF and HepaRG-Static cultures and significantly higher than the level of primary human hepatocytes (PHHs) (<xref ref-type="fig" rid="pone.0193664.g001">Fig 1B</xref>, <xref ref-type="supplementary-material" rid="pone.0193664.s004">S4 Table</xref>).</p><fig id="pone.0193664.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0193664.g001</object-id><label>Fig 1</label><caption><title>DMF-culturing enhances the differentiation of HepaRG cells.</title><p><bold>(A)</bold> Staining of albumin (green), and SOX9 (red), with DAPI counter-staining of the nuclei (blue) in HepaRG-Static and HepaRG-DMF. The arrow indicates the nuclear translocation of SOX9 in HepaRG-Static, scale bar = 50&#956;m. <bold>(B)</bold> Albumin synthesis. <bold>(C)</bold> Transcript levels of genes encoding hepatic transcription regulators, n = 6-9/group. Significance Static <italic toggle="yes">vs</italic> DMF: # = <italic toggle="yes">P</italic> value &lt;0.05, ## = <italic toggle="yes">P</italic> value &lt;0.01, ### = <italic toggle="yes">P</italic> value &lt;0.001 and #### = <italic toggle="yes">P</italic> value &lt;0.0001. <bold>(D)</bold> Staining for CEBP&#945; (red), with DAPI counter-staining of the nuclei (blue). The arrow indicates nuclear translocation of CEBP&#945;, observed in HepaRG-DMF, scale bar = 50&#956;m.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0193664.g001.jpg"/></fig><p>Furthermore, the transcript levels of critical hepatogenic differentiation regulators [<xref rid="pone.0193664.ref020" ref-type="bibr">20</xref>] hepatic nuclear factor 4 (<italic toggle="yes">HNF4</italic>), constitutive active receptor (<italic toggle="yes">CAR</italic>), pregnane X receptor (<italic toggle="yes">PXR</italic>), small heterodimer partner (<italic toggle="yes">SHP</italic>) and CCAAT/enhancer-binding protein (<italic toggle="yes">CEBPa</italic>) were increased by 1.5-, 2.3-, 1.8-, 1.8- and 2.9-fold, resp. in HepaRG-DMF <italic toggle="yes">vs</italic> HepaRG-Static (<xref ref-type="fig" rid="pone.0193664.g001">Fig 1C</xref>, <xref ref-type="supplementary-material" rid="pone.0193664.s002">S2 Table</xref>). Noteworthy, the transcript levels of <italic toggle="yes">HNF4</italic>, <italic toggle="yes">CAR</italic> and <italic toggle="yes">PXR</italic> were not changed in static HepaRG cultures supplemented with 2% DMSO compared to HepaRG-Static controls [<xref rid="pone.0193664.ref006" ref-type="bibr">6</xref>]. The expression of CEBP&#945;, a nuclear factor that regulates hepatic maturation and the urea cycle, was increased with more nuclear translocation in HepaRG-DMF compared to HepaRG-Static cultures (<xref ref-type="fig" rid="pone.0193664.g001">Fig 1D</xref> and, <xref ref-type="supplementary-material" rid="pone.0193664.s006">S2 Fig</xref> for higher resolution).</p></sec><sec id="sec013"><title>DMF-culturing improves nitrogen metabolism in HepaRG cells</title><p>We further assessed the effect of DMF-culturing on ammonia elimination, as one of the hallmark functions of hepatocytes. There are 2 principal routes of ammonia elimination in hepatocytes, either by irreversible conversion into urea through urea cycle activity or by reversible fixation into amino acids, primarily through the activity of glutamine synthase (GS) [<xref rid="pone.0193664.ref021" ref-type="bibr">21</xref>]. The urea cycle consists of 5 enzymatic reactions catalyzed by 5 enzymes with Carbamoyl Phosphate Synthetase I (CPS1) and Arginase 1 (ARG1) being two of the most critically expressed proteins in HepaRG cells [<xref rid="pone.0193664.ref006" ref-type="bibr">6</xref>]. ARG1 catalyzes the last step yielding urea and ornithine through hydrolysis of arginine, however, a similar reaction can be catalyzed by an extra-hepatic mitochondrial isoform, ARG2 [<xref rid="pone.0193664.ref022" ref-type="bibr">22</xref>, <xref rid="pone.0193664.ref023" ref-type="bibr">23</xref>]. DMF-culturing induced the transcript levels of <italic toggle="yes">CPS1</italic>, <italic toggle="yes">ARG1</italic> and <italic toggle="yes">GS</italic> 1.9-, 6.0- and 1.6-fold, resp. (<xref ref-type="fig" rid="pone.0193664.g002">Fig 2A</xref>, <xref ref-type="supplementary-material" rid="pone.0193664.s002">S2 Table</xref>). Consistent with this, ammonia elimination and urea production were 2.0- and 2.4-fold increased in the DMF-cultures resp., ammonia elimination was restored to the physiological level (<xref ref-type="fig" rid="pone.0193664.g002">Fig 2B and 2C</xref>, <xref ref-type="supplementary-material" rid="pone.0193664.s004">S4 Table</xref>). As <italic toggle="yes">ARG2</italic> transcript levels remained unchanged under DMF-culturing (<xref ref-type="fig" rid="pone.0193664.g002">Fig 2A</xref>, <xref ref-type="supplementary-material" rid="pone.0193664.s002">S2 Table</xref>), it is likely that the increased urea production under DMF can be attributed to increased urea cycle activity. In DMSO-treated static monolayers, the transcript levels of <italic toggle="yes">CPS1</italic> and <italic toggle="yes">GS</italic> were 28.2- and 2.4-fold decreased compared to HepaRG-Static monolayers. However, the ureagenesis and ammonia elimination were 1.6- and 1.5-fold upregulated compared to HepaRG-Static cultures [<xref rid="pone.0193664.ref006" ref-type="bibr">6</xref>].</p><fig id="pone.0193664.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0193664.g002</object-id><label>Fig 2</label><caption><title>DMF-culturing improves nitrogen metabolism in HepaRG cells.</title><p><bold>(A)</bold> Transcript levels of genes involved in nitrogen metabolism, n = 6/group. <bold>(B-C)</bold> Ammonia elimination and urea production, n = 9-18/group. Significance Static <italic toggle="yes">vs</italic> DMF: # = <italic toggle="yes">P</italic> value &lt;0.05, ## = <italic toggle="yes">P</italic> value &lt;0.01, ### = <italic toggle="yes">P</italic> value &lt;0.001 and #### = <italic toggle="yes">P</italic> value &lt;0.0001.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0193664.g002.jpg"/></fig><p>In brief, DMF-culturing improved ammonia metabolism of the HepaRG cells to higher extent compared to static cultures with or without DMSO supplementation.</p></sec><sec id="sec014"><title>DMF-culturing substantially increases the detoxification properties and bile acid production of HepaRG cells</title><p>DMF-culturing increased markers of detoxification at all three phases; phase 1, the alteration of the chemical structure to more water-soluble moiety, executed primarily by CYPs, phase 2 involving the conjugation of the hydrophilic moiety [<xref rid="pone.0193664.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0193664.ref025" ref-type="bibr">25</xref>], and phase 3, the transport into the canalicular space or circulation [<xref rid="pone.0193664.ref026" ref-type="bibr">26</xref>], as well as bile acid synthesis, which is essential for the secretion phase. The transcript level of <italic toggle="yes">CYP3A4</italic>, a CYP enzyme, involved in the detoxification process of 50% of prescribed drugs [<xref rid="pone.0193664.ref027" ref-type="bibr">27</xref>], was substantially upregulated up to 15-fold by DMF-culturing, whereas the transcript levels of <italic toggle="yes">CYP2B6</italic> and UDP-glucuronosyltransferase <italic toggle="yes">(UGT1a1</italic>) were 2.5- and 1.8-fold increased (<xref ref-type="fig" rid="pone.0193664.g003">Fig 3A</xref>, <xref ref-type="supplementary-material" rid="pone.0193664.s002">S2 Table</xref>). In the past, we found that DMSO-treatment increased the transcript levels of <italic toggle="yes">CYP2B6</italic> and <italic toggle="yes">CYP3A4</italic> 20.3- and 6.9-fold resp. [<xref rid="pone.0193664.ref006" ref-type="bibr">6</xref>]. Furthermore, the transcript level of cytochrome P450 oxidoreductase (<italic toggle="yes">POR</italic>), that donates electrons to CYPs, and is therefore essential for the biosynthesis of bile acid, as well as the metabolism of more than 80% of drugs in use [<xref rid="pone.0193664.ref028" ref-type="bibr">28</xref>, <xref rid="pone.0193664.ref029" ref-type="bibr">29</xref>], was 1.6-fold upregulated in DMF-cultures (<xref ref-type="fig" rid="pone.0193664.g003">Fig 3A</xref>, <xref ref-type="supplementary-material" rid="pone.0193664.s002">S2 Table</xref>). The substantial induction of <italic toggle="yes">CYP3A4</italic> transcript levels was in line with a 7.6- and 3.8-fold increase in the baseline and induced CYP3A4 activity (<xref ref-type="fig" rid="pone.0193664.g003">Fig 3B and 3C</xref>). Bile acid synthesis was 2.6-fold augmented in the DMF-cultures (<xref ref-type="fig" rid="pone.0193664.g003">Fig 3D</xref>, <xref ref-type="supplementary-material" rid="pone.0193664.s004">S4 Table</xref>). The transcript levels of hepatic uptake transporters Na+-taurocholate co-transporter poly peptide (<italic toggle="yes">NTCP</italic>) and organic anion transporter poly peptide (<italic toggle="yes">OATP1b1</italic>) were 2.7- and 2.3- fold induced under DMF-culturing, reaching 36.7% and 6.4% of human liver level, resp. (<xref ref-type="fig" rid="pone.0193664.g003">Fig 3E</xref>, <xref ref-type="supplementary-material" rid="pone.0193664.s002">S2 Table</xref>). In contrast, the already very low transcript level of <italic toggle="yes">OATP1b3</italic> compared to human liver being 1.2% for HepaRG-Static, was 2-fold further decreased by DMF-culturing. On the other hand, the transcript level of the efflux transporter multidrug resistance-associated protein <italic toggle="yes">MRP2</italic>, was 1.4-fold increased with DMF-culturing (<xref ref-type="fig" rid="pone.0193664.g003">Fig 3E</xref>, <xref ref-type="supplementary-material" rid="pone.0193664.s002">S2 Table</xref>).</p><fig id="pone.0193664.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0193664.g003</object-id><label>Fig 3</label><caption><title>DMF increases detoxification properties of HepaRG cells.</title><p><bold>(A)</bold> Transcript levels of detoxification genes, n = 6-9/group. <bold>(B-C)</bold> CYP3A4 baseline- and induced-activity, n = 6-15/group. <bold>(D)</bold> Bile acid production, n = 6-15/group. <bold>(E)</bold> Transcript levels of hepatic transporter genes, n = 6-9/group. (F) TC uptake, n = 6/group. Significance Static <italic toggle="yes">vs</italic> DMF: # = <italic toggle="yes">P</italic> value &lt;0.05, ## = <italic toggle="yes">P</italic> value &lt;0.01, ### = <italic toggle="yes">P</italic> value &lt;0.001 and #### = <italic toggle="yes">P</italic> value &lt;0.0001.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0193664.g003.jpg"/></fig><p>Unexpectedly, despite the significant increase of the transcript level of <italic toggle="yes">NTCP</italic>, no difference between DMF- and Static-cultures was observed in the taurocholate-uptake function of NTCP (<xref ref-type="fig" rid="pone.0193664.g003">Fig 3F</xref>).</p></sec><sec id="sec015"><title>DMF-culturing does not improve the polarization of the HepaRG cells</title><p>One of the important factors determining transporter function, is the polarization of the hepatocytes, resulting into distinct luminal and basolateral domains that execute the import and export, for <italic toggle="yes">e</italic>.<italic toggle="yes">g</italic>. proteins and bile acid [<xref rid="pone.0193664.ref030" ref-type="bibr">30</xref>]. The polarization of Static- and DMF-cultures was studied by immune-staining of OAPT1a1 and MRP2. The expression of OATP1a1 and MRP2 was increased in the DMF-cultures (<xref ref-type="fig" rid="pone.0193664.g004">Fig 4A and 4B</xref>). However, the localization of these hepatic transporters was predominantly cytosolic with minimal membrane localization, indicating that the polarization of the HepaRG cells was absent in both Static- and DMF-cultures. The disturbed polarization of the hepatic transporters was further confirmed by CFDA polarization assay. CFDA, upon entering hepatocytes, is converted into green fluorescent carboxyfluorescein (CF) by intracellular esterases, which then is effluxed to the canalicular side mainly through MRP2. Although CF-signal was increased in the DMF-cultures compared to Static-cultures, no clear canalicular localization was observed under both conditions, confirming that the polarization of the HepaRG cells was not yet established (<xref ref-type="fig" rid="pone.0193664.g004">Fig 4C</xref>).</p><fig id="pone.0193664.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0193664.g004</object-id><label>Fig 4</label><caption><title>DMF-culturing does not improve the polarization of the HepaRG cells.</title><p><bold>(A-B)</bold> Staining of hepatic transporters OATP1a1(green) and MRP2 (red) with DAPI counter-staining for the nuclei (blue). <bold>(C)</bold> Visualization of CFDA (green) with DAPI counter-staining of the nuclei (blue), scale bar = 50&#956;m.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0193664.g004.jpg"/></fig></sec><sec id="sec016"><title>DMF-culturing induces a shift in cellular energy metabolism towards more mitochondrial-dependent in HepaRG cells</title><p>Previously, we found that culturing of HepaRG cells under DMF increased mitochondrial abundance and OxPhos complexes [<xref rid="pone.0193664.ref011" ref-type="bibr">11</xref>]. Here, we further assessed cellular-energy metabolism and mitochondrial functions. In agreement with the previous findings, the transcript level of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (<italic toggle="yes">PGC1a</italic>), the master regulator of mitochondrial biogenesis, was 1.4-fold increased under DMF (<xref ref-type="fig" rid="pone.0193664.g005">Fig 5A</xref>, <xref ref-type="supplementary-material" rid="pone.0193664.s002">S2 Table</xref>). Moreover, the transcript levels of mitochondrially-encoded cytochrome B gene (<italic toggle="yes">MT-CYB</italic>) was 1.7-fold enhanced (<xref ref-type="fig" rid="pone.0193664.g005">Fig 5A</xref>, <xref ref-type="supplementary-material" rid="pone.0193664.s002">S2 Table</xref>). Furthermore, lactate production and glucose consumption were 1.9- and 2.5-fold reduced, whereas oxygen consumption was 1.6-fold increased in DMF-HepaRG <italic toggle="yes">vs</italic> HepaRG-Static cultures (<xref ref-type="fig" rid="pone.0193664.g005">Fig 5B&#8211;5D</xref>). Collectively, these data confirm that DMF-culturing enhances mitochondrial functions and exerts a shift in cellular-energy metabolism towards OxPhos in HepaRG cells.</p><fig id="pone.0193664.g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0193664.g005</object-id><label>Fig 5</label><caption><title>DMF increases mitochondrial energy metabolism of HepaRG cells.</title><p><bold>(A)</bold> Transcript levels of <italic toggle="yes">PGC1a</italic> and <italic toggle="yes">MT-CYB</italic>, n = 6/group. <bold>(B-D)</bold> Lactate production, glucose and oxygen consumption, n = 9-15/group. Significance Static <italic toggle="yes">vs</italic> DMF: # = <italic toggle="yes">P</italic> value &lt;0.05, ## = <italic toggle="yes">P</italic> value &lt;0.01, ### = <italic toggle="yes">P</italic> value &lt;0.001 and #### = <italic toggle="yes">P</italic> value &lt;0.0001.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0193664.g005.jpg"/></fig></sec><sec id="sec017"><title>DMF-culturing substantially stimulates hepatic functions and mitochondrial metabolism of C3A cells</title><p>To assess whether the effect of DMF-culturing is cell line (HepaRG) specific, we also compared Static and DMF-cultures of the C3A cell line. Compared to C3A-Static, C3A-DMF relied more on mitochondrial energy metabolism, as indicated by a 3.2- and 2.3-fold reduced lactate production and glucose consumption, resp. (<xref ref-type="fig" rid="pone.0193664.g006">Fig 6A and 6B</xref>). In addition, DMF-culturing increased hepatic differentiation, as indicated by a 1.9-,3.1- and 5.6-fold induction of the transcript levels of <italic toggle="yes">HNF4</italic>, <italic toggle="yes">CAR</italic> and <italic toggle="yes">CEBP&#945;</italic>, while <italic toggle="yes">PXR</italic> and <italic toggle="yes">SHP</italic> exhibited a positive trend (<xref ref-type="fig" rid="pone.0193664.g006">Fig 6C</xref>, <xref ref-type="supplementary-material" rid="pone.0193664.s003">S3 Table</xref>). Unexpectedly, Albumin synthesis was reduced in C3A-DMF cultures compared to C3A-Static (<xref ref-type="fig" rid="pone.0193664.g006">Fig 6D</xref>, <xref ref-type="supplementary-material" rid="pone.0193664.s004">S4 Table</xref>). On the other hand, the baseline and induced-CYP3A4 activity was 2.5- and 4.7- fold increased by DMF-culturing (<xref ref-type="fig" rid="pone.0193664.g006">Fig 6E and 6F</xref>). In contrast to HepaRG cells, C3A cells produce ammonia and are not capable of eliminating ammonia. C3A cells maintained under DMF-cultures displayed an improved ammonia metabolism, as shown by induction of the transcript levels of the genes encoding urea cycle enzymes <italic toggle="yes">CPS1</italic> and <italic toggle="yes">OTC</italic>, 3.0- and 4.0-fold, resp., whereas the levels of <italic toggle="yes">ARG1</italic> and <italic toggle="yes">GS</italic> remained comparable to that of Static-cultures (<xref ref-type="fig" rid="pone.0193664.g006">Fig 6G</xref>, <xref ref-type="supplementary-material" rid="pone.0193664.s003">S3 Table</xref>). Accordingly, ammonia metabolism was positively modulated, resulting in a 3.3-fold less ammonia production, while urea production remained unchanged (<xref ref-type="fig" rid="pone.0193664.g006">Fig 6H and 6I</xref>).</p><fig id="pone.0193664.g006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0193664.g006</object-id><label>Fig 6</label><caption><title>DMF-culturing enhances mitochondrial energy metabolism and hepatic functions of C3A cells.</title><p><bold>(A-B)</bold> Lactate production and glucose consumption, n = 6/group. <bold>(C)</bold> Transcript levels of genes encoding hepatic differentiation regulators, n = 6/group. (D) Albumin synthesis. <bold>(E-F)</bold> CYP3A4 activity, n = 3/group. <bold>(G)</bold> Transcript levels of genes involved in nitrogen metabolism, n = 6/group. <bold>(H-I)</bold> Ammonia elimination and urea production, n = 3-6/group. Significance Static <italic toggle="yes">vs</italic> DMF: # = <italic toggle="yes">P</italic> value &lt;0.05, ## = <italic toggle="yes">P</italic> value &lt;0.01, ### = <italic toggle="yes">P</italic> value &lt;0.001 and #### = <italic toggle="yes">P</italic> value &lt;0.0001.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0193664.g006.jpg"/></fig></sec></sec><sec sec-type="conclusions" id="sec018"><title>Discussion</title><p>There is an unmet need for a hepatocyte culture platform that either maintains the hepatic functionality of primary hepatocytes and/or induces hepatic functionality of proliferative sources of hepatocytes, such as stem cells and cell lines. This study presents a practice-changing culture method comprised of simply shaking of monolayer cultures after reaching confluence, which substantially increases the hepatic functionality and shifts energy metabolism towards OxPhos of two hepatocyte cell lines, HepaRG and C3A.</p><p>Recently, DMF was found to be one of the factors contributing to the enhanced mitochondrial biogenesis under AMC-BAL-culturing [<xref rid="pone.0193664.ref011" ref-type="bibr">11</xref>]. In this study, we further established that DMF-culturing exerted a clear shift in energy metabolism from aerobic glycolysis towards OxPhos, as indicated by the significant decline in lactate production, and glucose consumption in both HepaRG and C3A cell lines and, only tested in HepaRG cells, an increase in oxygen consumption. Additionally, DMF upregulated hepatic transcription factors and hepatic functions of HepaRG and C3A cells, including ammonia metabolism and CYP3A4 activity. More extended studies, in HepaRG cells, showed that DMF induced the transcript levels of various hepatic genes, bile acid synthesis, whereas the expression of the stem cell marker SOX9 was reduced, and its localization was shifted from nuclear towards cytoplasmic, indicating a higher degree of hepatic differentiation under DMF. Therefore, we established a simple modification to conventional culturing methods that upregulates mitochondrial energy metabolism and hepatic differentiation of liver cell lines.</p><p>Solid association between mitochondrial energy metabolism and differentiation has recently been established, particularly in stem cell research. Undifferentiated stem cells retain pluripotency and high proliferative potentials under glycolysis-stimulating conditions [<xref rid="pone.0193664.ref031" ref-type="bibr">31</xref>, <xref rid="pone.0193664.ref032" ref-type="bibr">32</xref>]. Furthermore, reverse mitochondrial remodeling occurs during reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) and during dedifferentiation of primary hepatocytes [<xref rid="pone.0193664.ref016" ref-type="bibr">16</xref>]. Conversely, differentiation of stem cells is associated with mitochondrial remodeling and a shift of energy metabolism towards OxPhos [<xref rid="pone.0193664.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0193664.ref033" ref-type="bibr">33</xref>].</p><p>Although, the hepatic functions of the C3A cells were significantly increased under DMF-culturing, yet ammonia production was not converted into elimination rendering the usage of this cell line as a biocomponent in BALs to support patients with liver failure, questionable. Importantly, the effect of DMF-culturing on the hepatic differentiation of different liver cell lines may vary in its magnitude dependant on the basal hepatic differentiation of the specific cell line under static conditions.</p><p>The importance of DMF for HepaRG cells was already shown in the AMC-BAL culture platform [<xref rid="pone.0193664.ref034" ref-type="bibr">34</xref>]. A medium flow rate of 5 ml/min optimally stimulated hepatic functions, whereas lower and higher flow rates resulted in decreased functionality and increased cell damage, resp. Here, we mimicked DMF of the BAL system in monolayers using a simple technique by continuously shaking the cultures at 60 rpm rate during the differentiation phase. Lower shaking rates, being 5 and 25 rpm, were not effective (<xref ref-type="supplementary-material" rid="pone.0193664.s007">S3 Fig</xref>). In addition, DMF of less dense (sub-confluent) cultures was detrimental to the cells; DMF starting at 3 days after seeding, instead of 14 days, lead to &gt;80% cell death, as observed microscopically.</p><p>DMF has also been applied for hepatocyte culturing by others, relying on complex systems, such as microfluidic chambers [<xref rid="pone.0193664.ref035" ref-type="bibr">35</xref>&#8211;<xref rid="pone.0193664.ref038" ref-type="bibr">38</xref>]. Importantly, unlike DMF by simple shaking applied in our study, in all above mentioned DMF platforms, an internal oxygenation system was crucial for the viability and functionality of the hepatocytes in agreement with the assumption that improved oxygenation under shaking, stimulates mitochondrial biogenesis and thereby hepatic differentiation. Consistent with this, we recently established that oxygenation with 40%O<sub>2</sub> instead of 20%O<sub>2</sub> increased mitochondrial biogenesis, and hepatic differentiation of HepaRG cells Static-monolayers, however not to the level of DMF-culturing [<xref rid="pone.0193664.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0193664.ref039" ref-type="bibr">39</xref>], suggesting a shared underlying mechanism, relying, at least in part, on improved oxygenation, however this requires further investigations.</p><p>Interestingly, culturing of the HepaRG cells under DMF increased their hepatic differentiation superior to DMSO-treatment, without inducing any cytotoxic effect, as found for DMSO-treatment [<xref rid="pone.0193664.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0193664.ref006" ref-type="bibr">6</xref>]. Ammonia metabolism and the transcript levels of several hepatic genes (<italic toggle="yes">e</italic>.<italic toggle="yes">g</italic>. <italic toggle="yes">HNF4</italic>, <italic toggle="yes">PXR</italic>, <italic toggle="yes">CAR</italic> and <italic toggle="yes">CYP3A4</italic>) were relatively high in the HepaRG-DMF cultures, while only the transcript level of <italic toggle="yes">CYP2B6</italic> among all tested hepatic genes, was more upregulated by DMSO-treatment <italic toggle="yes">vs</italic>. DMF culturing.</p><p>The DMF-induced gain of hepatic functionality is probably mediated through upregulation of hepatogenic transcription factors. DMF increased the transcript levels of <italic toggle="yes">HNF4</italic>, <italic toggle="yes">CEBPa</italic> and <italic toggle="yes">CAR</italic> in HepaRG and C3A cells, whereas <italic toggle="yes">PXR</italic> and <italic toggle="yes">SHP</italic>, were induced in HepaRG cells. SHP mediates FXR signaling as a small heterodimer partner. Among other functions, FXR acts as a transcriptional regulator of bile acid biosynthesis and transport in liver [<xref rid="pone.0193664.ref040" ref-type="bibr">40</xref>]. Interestingly, Godoy <italic toggle="yes">et al</italic>. found that three of these regulators, <italic toggle="yes">i</italic>.<italic toggle="yes">e</italic>. <italic toggle="yes">CAR</italic>, <italic toggle="yes">FXR</italic> and <italic toggle="yes">PXR</italic>, were, together with <italic toggle="yes">HNF1</italic>, strongly repressed in cultivated hepatocytes, suggesting that the current <italic toggle="yes">in vitro</italic> culturing models lack stimuli required to maintain gene expression of these regulators in hepatocytes [<xref rid="pone.0193664.ref041" ref-type="bibr">41</xref>], which can be counteracted by DMF-culturing. The upregulation of <italic toggle="yes">HNF4</italic> and <italic toggle="yes">CEBPa</italic> will also contribute to hepatic functionality, as these two transcription factors play a major role in governing hepatic development and regulating a number of critical metabolic pathways, including the urea cycle [<xref rid="pone.0193664.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0193664.ref043" ref-type="bibr">43</xref>]. CEBP<italic toggle="yes">a</italic> overexpression in combination with HNF4 and FOX2a in adult-liver derived progenitor cells resulted in increased hepatic differentiation [<xref rid="pone.0193664.ref044" ref-type="bibr">44</xref>].</p><p>Of note, in HepaRG cells, the production of bile acids, being versatile signaling molecules, was 2.6-fold augmented by DMF-culturing, which may further upregulate FXR, CAR, PXR and other relevant pathways, as cAMP synthesis, and protein kinase C activation [<xref rid="pone.0193664.ref045" ref-type="bibr">45</xref>]. Interestingly, DMF-culturing did not increase albumin synthesis in HepaRG cells and resulted in a reduced albumin production by C3A cells. This unexpected observation might be related to the fact that albumin production is already higher or comparable to the level of human primary hepatocytes in HepaRG and C3A cells cultures resp and could not be further increased by DMF-culturing.</p><p>The expression of several hepatic transporters, that were relatively low expressed in HepaRG-Static monolayers, such as NTCP, was increased in HepaRG-DMF cultures, however probably due to limited polarization, NTCP function remained unchanged. Hepatocyte polarization is a complex process, leading to an organized localization of extracellular, cytoskeletal and tight junction molecules [<xref rid="pone.0193664.ref046" ref-type="bibr">46</xref>]. The polarization is more established in HepaRG monolayers when treated with 1.7% DMSO for the last two weeks of culturing [<xref rid="pone.0193664.ref047" ref-type="bibr">47</xref>]. In the past increased polarization of HepaRG cells was achieved by AMC-BAL culturing of HepaRG cells [<xref rid="pone.0193664.ref026" ref-type="bibr">26</xref>]. Therefore, new culture techniques combining DMF by simple shaking and 3D configuration may thus represent a potential window for further improving <italic toggle="yes">in vitro</italic> hepatocyte culturing.</p></sec><sec sec-type="conclusions" id="sec019"><title>Conclusions</title><p>The current study demonstrates that DMF-culturing substantially enhances mitochondrial energy metabolism and hepatic functions in two different human liver cell lines. These findings strongly support a role of mitochondria in regulating the differentiation of human liver cells. Importantly, we developed a new easily applicable and scalable culture platform that substantially enhances the functionality of human liver cell lines. Considering the high similarity of responsiveness to DMF-culturing between two hepatic cell lines, it is likely that DMF will also exert positive effects on hepatic differentiation of stem cells and maintenance of differentiation of primary hepatocytes.</p></sec><sec sec-type="supplementary-material" id="sec020"><title>Supporting information</title><supplementary-material content-type="local-data" id="pone.0193664.s001" position="float" orientation="portrait"><label>S1 Table</label><caption><title>Primers used in the RT-qPCR and amplicon size.</title><p>(DOC)</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0193664.s001.doc" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0193664.s002" position="float" orientation="portrait"><label>S2 Table</label><caption><title>Transcript levels of genes in HepaRG cultures as a % of human livers.</title><p>(DOC)</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0193664.s002.doc" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0193664.s003" position="float" orientation="portrait"><label>S3 Table</label><caption><title>Transcript levels of genes in C3A cultures as a % of human livers.</title><p>(DOC)</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0193664.s003.doc" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0193664.s004" position="float" orientation="portrait"><label>S4 Table</label><caption><title>Hepatic functions of primary human hepatocytes (PHHs), HepaRG and C3A static and DMF-cultures.</title><p>Values are given as mean&#177;SD, for more details [<xref rid="pone.0193664.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0193664.ref048" ref-type="bibr">48</xref>].</p><p>(DOC)</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0193664.s004.doc" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0193664.s005" position="float" orientation="portrait"><label>S1 Fig</label><caption><title>Higher resolution staining of albumin (green), and SOX9 (red), with DAPI counter-staining of the nuclei (blue) in HepaRG-Static, HepaRG-DMSO-Static and HepaRG-DMF cultures.</title><p>The arrow indicates the nuclear translocation of SOX9 in HepaRG-Static, scale bar = 50&#956;m.</p><p>(TIF)</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0193664.s005.tif" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0193664.s006" position="float" orientation="portrait"><label>S2 Fig</label><caption><title>Higher resolution staining for CEBP&#945; (red), with DAPI counter-staining of the nuclei (blue) in HepaRG-Static, HepaRG-DMSO-Static and HepaRG-DMF cultures.</title><p>The arrow indicates nuclear translocation of CEBP&#945;, observed in HepaRG-DMF, scale bar = 50&#956;m.</p><p>(TIF)</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0193664.s006.tif" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0193664.s007" position="float" orientation="portrait"><label>S3 Fig</label><caption><title>Optimization of the shaking rate for DMF-cultures.</title><p>Briefly, HepaRG monolayers were kept statically for two weeks (the proliferation phase), then cultures were moved to a shaking incubator with 5, 25 or 60 rpm during the differentiation phase (the last two weeks of culturing). Hepatic functionality was evaluated for ammonia elimination, urea production and lactate production, of different DMF-cultures, compared to HepaRG-Static cultures.</p><p>(TIF)</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0193664.s007.tif" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0193664.s008" position="float" orientation="portrait"><label>S1 Data</label><caption><title>Excel sheet with all raw data.</title><p>(XLS)</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0193664.s008.xls" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank Erik Hendriks for cell culturing and Applikon Biotechnology for providing the SDR SensorDish&#174; Reader.</p></ack><ref-list><title>References</title><ref id="pone.0193664.ref001"><label>1</label><mixed-citation publication-type="journal"><name name-style="western"><surname>van Wenum</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chamuleau</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>van Gulik</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Siliakus</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Seppen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hoekstra</surname><given-names>R</given-names></name>. <article-title>Bioartificial livers in vitro and in vivo: tailoring biocomponents to the expanding variety of applications</article-title>. <source>Expert Opin Biol Ther</source>. <year>2014</year>;<volume>14</volume>(<issue>12</issue>):<fpage>1745</fpage>&#8211;<lpage>60</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1517/14712598.2014.950651">10.1517/14712598.2014.950651</ext-link></comment><pub-id pub-id-type="pmid">25366164</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1517/14712598.2014.950651</pub-id></mixed-citation></ref><ref id="pone.0193664.ref002"><label>2</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Gerets</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Tilmant</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Gerin</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Chanteux</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Depelchin</surname><given-names>BO</given-names></name>, <name name-style="western"><surname>Dhalluin</surname><given-names>S</given-names></name>, <etal>et al</etal><article-title>Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins</article-title>. <source>Cell Biol Toxicol</source>. <year>2012</year>;<volume>28</volume>(<issue>2</issue>):<fpage>69</fpage>&#8211;<lpage>87</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10565-011-9208-4">10.1007/s10565-011-9208-4</ext-link></comment><pub-id pub-id-type="pmid">22258563</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10565-011-9208-4</pub-id><pub-id pub-id-type="pmcid">PMC3303072</pub-id></mixed-citation></ref><ref id="pone.0193664.ref003"><label>3</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Gripon</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Rumin</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Urban</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Le Seyec</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Glaise</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Cannie</surname><given-names>I</given-names></name>, <etal>et al</etal><article-title>Infection of a human hepatoma cell line by hepatitis B virus</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2002</year>;<volume>99</volume>(<issue>24</issue>):<fpage>15655</fpage>&#8211;<lpage>60</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.232137699">10.1073/pnas.232137699</ext-link></comment><pub-id pub-id-type="pmid">12432097</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.232137699</pub-id><pub-id pub-id-type="pmcid">PMC137772</pub-id></mixed-citation></ref><ref id="pone.0193664.ref004"><label>4</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Nibourg</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Chamuleau</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>van der Hoeven</surname><given-names>TV</given-names></name>, <name name-style="western"><surname>Maas</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Ruiter</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Lamers</surname><given-names>WH</given-names></name>, <etal>et al</etal><article-title>Liver progenitor cell line HepaRG differentiated in a bioartificial liver effectively supplies liver support to rats with acute liver failure</article-title>. <source>PLoS One</source>. <year>2012</year>;<volume>7</volume>(<issue>6</issue>):<fpage>e38778</fpage><comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0038778">10.1371/journal.pone.0038778</ext-link></comment><pub-id pub-id-type="pmid">22719943</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0038778</pub-id><pub-id pub-id-type="pmcid">PMC3377721</pub-id></mixed-citation></ref><ref id="pone.0193664.ref005"><label>5</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Gao</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name>. <article-title>A transcriptomic study suggesting human iPSC-derived hepatocytes potentially offer a better in vitro model of hepatotoxicity than most hepatoma cell lines</article-title>. <source>Cell Biol Toxicol</source>. <year>2017</year>;<volume>33</volume>(<issue>4</issue>):<fpage>407</fpage>&#8211;<lpage>21</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10565-017-9383-z">10.1007/s10565-017-9383-z</ext-link></comment><pub-id pub-id-type="pmid">28144825</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10565-017-9383-z</pub-id></mixed-citation></ref><ref id="pone.0193664.ref006"><label>6</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hoekstra</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Nibourg</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>van der Hoeven</surname><given-names>TV</given-names></name>, <name name-style="western"><surname>Ackermans</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Hakvoort</surname><given-names>TB</given-names></name>, <name name-style="western"><surname>van Gulik</surname><given-names>TM</given-names></name>, <etal>et al</etal><article-title>The HepaRG cell line is suitable for bioartificial liver application</article-title>. <source>Int J Biochem Cell Biol</source>. <year>2011</year>;<volume>43</volume>(<issue>10</issue>):<fpage>1483</fpage>&#8211;<lpage>9</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.biocel.2011.06.011">10.1016/j.biocel.2011.06.011</ext-link></comment><pub-id pub-id-type="pmid">21726661</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biocel.2011.06.011</pub-id></mixed-citation></ref><ref id="pone.0193664.ref007"><label>7</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Nibourg</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Hoekstra</surname><given-names>R</given-names></name>, <name name-style="western"><surname>van der Hoeven</surname><given-names>TV</given-names></name>, <name name-style="western"><surname>Ackermans</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Hakvoort</surname><given-names>TB</given-names></name>, <name name-style="western"><surname>van Gulik</surname><given-names>TM</given-names></name>, <etal>et al</etal><article-title>Increased hepatic functionality of the human hepatoma cell line HepaRG cultured in the AMC bioreactor</article-title>. <source>IntJBiochemCell Biol</source>. <year>2013</year>;<volume>45</volume>(<issue>8</issue>):<fpage>1860</fpage>&#8211;<lpage>8</lpage>. S1357-2725(13)00186-6 [pii]; <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.biocel.2013.05.038">10.1016/j.biocel.2013.05.038</ext-link></comment><pub-id pub-id-type="pmid">23770120</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biocel.2013.05.038</pub-id></mixed-citation></ref><ref id="pone.0193664.ref008"><label>8</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Nibourg</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Chamuleau</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>van Gulik</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Hoekstra</surname><given-names>R</given-names></name>. <article-title>Proliferative human cell sources applied as biocomponent in bioartificial livers: a review</article-title>. <source>Expert Opin Biol Ther</source>. <year>2012</year>;<volume>12</volume>(<issue>7</issue>):<fpage>905</fpage>&#8211;<lpage>21</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1517/14712598.2012.685714">10.1517/14712598.2012.685714</ext-link></comment><pub-id pub-id-type="pmid">22650303</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1517/14712598.2012.685714</pub-id></mixed-citation></ref><ref id="pone.0193664.ref009"><label>9</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Nibourg</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Hoekstra</surname><given-names>R</given-names></name>, <name name-style="western"><surname>van der Hoeven</surname><given-names>TV</given-names></name>, <name name-style="western"><surname>Ackermans</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Hakvoort</surname><given-names>TB</given-names></name>, <name name-style="western"><surname>van Gulik</surname><given-names>TM</given-names></name>, <etal>et al</etal><article-title>Increased hepatic functionality of the human hepatoma cell line HepaRG cultured in the AMC bioreactor</article-title>. <source>Int J Biochem Cell Biol</source>. <year>2013</year>;<volume>45</volume>(<issue>8</issue>):<fpage>1860</fpage>&#8211;<lpage>8</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.biocel.2013.05.038">10.1016/j.biocel.2013.05.038</ext-link></comment><pub-id pub-id-type="pmid">23770120</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biocel.2013.05.038</pub-id></mixed-citation></ref><ref id="pone.0193664.ref010"><label>10</label><mixed-citation publication-type="journal"><name name-style="western"><surname>van Wenum</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Adam</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Hakvoort</surname><given-names>TB</given-names></name>, <name name-style="western"><surname>Hendriks</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Shevchenko</surname><given-names>V</given-names></name>, <name name-style="western"><surname>van Gulik</surname><given-names>TM</given-names></name>, <etal>et al</etal><article-title>Selecting Cells for Bioartificial Liver Devices and the Importance of a 3D Culture Environment: A Functional Comparison between the HepaRG and C3A Cell Lines</article-title>. <source>Int J Biol Sci</source>. <year>2016</year>;<volume>12</volume>(<issue>8</issue>):<fpage>964</fpage>&#8211;<lpage>78</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.7150/ijbs.15165">10.7150/ijbs.15165</ext-link></comment><pub-id pub-id-type="pmid">27489500</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7150/ijbs.15165</pub-id><pub-id pub-id-type="pmcid">PMC4971735</pub-id></mixed-citation></ref><ref id="pone.0193664.ref011"><label>11</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Adam</surname><given-names>AAA</given-names></name>, <name name-style="western"><surname>van Wenum</surname><given-names>M</given-names></name>, <name name-style="western"><surname>van der Mark</surname><given-names>VA</given-names></name>, <name name-style="western"><surname>Jongejan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Moerland</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Houtkooper</surname><given-names>RH</given-names></name>, <etal>et al</etal><article-title>AMC-Bio-Artificial Liver culturing enhances mitochondrial biogenesis in human liver cell lines: The role of oxygen, medium perfusion and 3D configuration</article-title>. <source>Mitochondrion</source>. <year>2018</year>;<volume>39</volume>:<fpage>30</fpage>&#8211;<lpage>42</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.mito.2017.08.011">10.1016/j.mito.2017.08.011</ext-link></comment><pub-id pub-id-type="pmid">28844938</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mito.2017.08.011</pub-id></mixed-citation></ref><ref id="pone.0193664.ref012"><label>12</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Knowles</surname><given-names>BB</given-names></name>, <name name-style="western"><surname>Howe</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Aden</surname><given-names>DP</given-names></name>. <article-title>Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen</article-title>. <source>Science</source>. <year>1980</year>;<volume>209</volume>(<issue>4455</issue>):<fpage>497</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="pmid">6248960</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.6248960</pub-id></mixed-citation></ref><ref id="pone.0193664.ref013"><label>13</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Nibourg</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Boer</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>van der Hoeven</surname><given-names>TV</given-names></name>, <name name-style="western"><surname>Ackermans</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>van Gulik</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Chamuleau</surname><given-names>RA</given-names></name>, <etal>et al</etal><article-title>Perfusion flow rate substantially contributes to the performance of the HepaRG-AMC-bioartificial liver</article-title>. <source>Biotechnol Bioeng</source>. <year>2012</year>;<volume>109</volume>(<issue>12</issue>):<fpage>3182</fpage>&#8211;<lpage>8</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1002/bit.24586">10.1002/bit.24586</ext-link></comment><pub-id pub-id-type="pmid">22729831</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/bit.24586</pub-id></mixed-citation></ref><ref id="pone.0193664.ref014"><label>14</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kondoh</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lleonart</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Nakashima</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yokode</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tanaka</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bernard</surname><given-names>D</given-names></name>, <etal>et al</etal><article-title>A high glycolytic flux supports the proliferative potential of murine embryonic stem cells</article-title>. <source>Antioxid Redox Signal</source>. <year>2007</year>;<volume>9</volume>(<issue>3</issue>):<fpage>293</fpage>&#8211;<lpage>9</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1089/ars.2006.1467">10.1089/ars.2006.1467</ext-link></comment><pub-id pub-id-type="pmid">17184172</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/ars.2006.1467</pub-id></mixed-citation></ref><ref id="pone.0193664.ref015"><label>15</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Varum</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Momcilovic</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Castro</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ben-Yehudah</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ramalho-Santos</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Navara</surname><given-names>CS</given-names></name>. <article-title>Enhancement of human embryonic stem cell pluripotency through inhibition of the mitochondrial respiratory chain</article-title>. <source>Stem Cell Res</source>. <year>2009</year>;<volume>3</volume>(<issue>2&#8211;3</issue>):<fpage>142</fpage>&#8211;<lpage>56</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.scr.2009.07.002">10.1016/j.scr.2009.07.002</ext-link></comment><pub-id pub-id-type="pmid">19716358</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.scr.2009.07.002</pub-id><pub-id pub-id-type="pmcid">PMC2837416</pub-id></mixed-citation></ref><ref id="pone.0193664.ref016"><label>16</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wanet</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Remacle</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Najar</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sokal</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Arnould</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Najimi</surname><given-names>M</given-names></name>, <etal>et al</etal><article-title>Mitochondrial remodeling in hepatic differentiation and dedifferentiation</article-title>. <source>Int J Biochem Cell Biol</source>. <year>2014</year>;<volume>54</volume>:<fpage>174</fpage>&#8211;<lpage>85</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.biocel.2014.07.015">10.1016/j.biocel.2014.07.015</ext-link></comment><pub-id pub-id-type="pmid">25084555</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biocel.2014.07.015</pub-id></mixed-citation></ref><ref id="pone.0193664.ref017"><label>17</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Appelman</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Chakraborty</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Protzer</surname><given-names>U</given-names></name>, <name name-style="western"><surname>McKeating</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>van de Graaf</surname><given-names>SF</given-names></name>. <article-title>N-Glycosylation of the Na+-Taurocholate Cotransporting Polypeptide (NTCP) Determines Its Trafficking and Stability and Is Required for Hepatitis B Virus Infection</article-title>. <source>PLoS One</source>. <year>2017</year>;<volume>12</volume>(<issue>1</issue>):<fpage>e0170419</fpage><comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0170419">10.1371/journal.pone.0170419</ext-link></comment><pub-id pub-id-type="pmid">28125599</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0170419</pub-id><pub-id pub-id-type="pmcid">PMC5268470</pub-id></mixed-citation></ref><ref id="pone.0193664.ref018"><label>18</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Jo</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Denduluri</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Yin</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Yan</surname><given-names>Z</given-names></name>, <etal>et al</etal><article-title>The versatile functions of Sox9 in development, stem cells, and human diseases</article-title>. <source>Genes Dis</source>. <year>2014</year>;<volume>1</volume>(<issue>2</issue>):<fpage>149</fpage>&#8211;<lpage>61</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.gendis.2014.09.004">10.1016/j.gendis.2014.09.004</ext-link></comment><pub-id pub-id-type="pmid">25685828</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.gendis.2014.09.004</pub-id><pub-id pub-id-type="pmcid">PMC4326072</pub-id></mixed-citation></ref><ref id="pone.0193664.ref019"><label>19</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Furuyama</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kawaguchi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Akiyama</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Horiguchi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kodama</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kuhara</surname><given-names>T</given-names></name>, <etal>et al</etal><article-title>Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine</article-title>. <source>Nat Genet</source>. <year>2011</year>;<volume>43</volume>(<issue>1</issue>):<fpage>34</fpage>&#8211;<lpage>41</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng.722">10.1038/ng.722</ext-link></comment><pub-id pub-id-type="pmid">21113154</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ng.722</pub-id></mixed-citation></ref><ref id="pone.0193664.ref020"><label>20</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lauschke</surname><given-names>VM</given-names></name>, <name name-style="western"><surname>Vorrink</surname><given-names>SU</given-names></name>, <name name-style="western"><surname>Moro</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Rezayee</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Nordling</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hendriks</surname><given-names>DF</given-names></name>, <etal>et al</etal><article-title>Massive rearrangements of cellular MicroRNA signatures are key drivers of hepatocyte dedifferentiation</article-title>. <source>Hepatology</source>. <year>2016</year>;<volume>64</volume>(<issue>5</issue>):<fpage>1743</fpage>&#8211;<lpage>56</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1002/hep.28780">10.1002/hep.28780</ext-link></comment><pub-id pub-id-type="pmid">27532775</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/hep.28780</pub-id></mixed-citation></ref><ref id="pone.0193664.ref021"><label>21</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Haussinger</surname><given-names>D</given-names></name>. <article-title>Regulation of hepatic ammonia metabolism: the intercellular glutamine cycle</article-title>. <source>Adv Enzyme Regul</source>. <year>1986</year>;<volume>25</volume>:<fpage>159</fpage>&#8211;<lpage>80</lpage>. <pub-id pub-id-type="pmid">2880476</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0065-2571(86)90013-0</pub-id></mixed-citation></ref><ref id="pone.0193664.ref022"><label>22</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Almada</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Bellarosa</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Giraudi</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Mamprin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mediavilla</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Guibert</surname><given-names>E</given-names></name>, <etal>et al</etal><article-title>Gene expression and activity of urea cycle enzymes of rat hepatocytes cold stored up to 120h in University of Wisconsin solution</article-title>. <source>Cryobiology</source>. <year>2006</year>;<volume>52</volume>(<issue>3</issue>):<fpage>393</fpage>&#8211;<lpage>400</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cryobiol.2006.02.001">10.1016/j.cryobiol.2006.02.001</ext-link></comment><pub-id pub-id-type="pmid">16546154</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cryobiol.2006.02.001</pub-id></mixed-citation></ref><ref id="pone.0193664.ref023"><label>23</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Miyanaka</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Gotoh</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Nagasaki</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Takeya</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ozaki</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Iwase</surname><given-names>K</given-names></name>, <etal>et al</etal><article-title>Immunohistochemical localization of arginase II and other enzymes of arginine metabolism in rat kidney and liver</article-title>. <source>Histochem J</source>. <year>1998</year>;<volume>30</volume>(<issue>10</issue>):<fpage>741</fpage>&#8211;<lpage>51</lpage>. <pub-id pub-id-type="pmid">9874001</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1023/a:1003468726969</pub-id></mixed-citation></ref><ref id="pone.0193664.ref024"><label>24</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hu</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Meech</surname><given-names>R</given-names></name>, <name name-style="western"><surname>McKinnon</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Mackenzie</surname><given-names>PI</given-names></name>. <article-title>Transcriptional regulation of human UDP-glucuronosyltransferase genes</article-title>. <source>Drug Metab Rev</source>. <year>2014</year>;<volume>46</volume>(<issue>4</issue>):<fpage>421</fpage>&#8211;<lpage>58</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.3109/03602532.2014.973037">10.3109/03602532.2014.973037</ext-link></comment><pub-id pub-id-type="pmid">25336387</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/03602532.2014.973037</pub-id></mixed-citation></ref><ref id="pone.0193664.ref025"><label>25</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Williams</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Ring</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Cantrell</surname><given-names>VE</given-names></name>, <name name-style="western"><surname>Campanale</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Hall</surname><given-names>SD</given-names></name>, <etal>et al</etal><article-title>Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes</article-title>. <source>Drug Metab Dispos</source>. <year>2002</year>;<volume>30</volume>(<issue>11</issue>):<fpage>1266</fpage>&#8211;<lpage>73</lpage>. <pub-id pub-id-type="pmid">12386134</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.30.11.1266</pub-id></mixed-citation></ref><ref id="pone.0193664.ref026"><label>26</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hoekstra</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Nibourg</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>van der Hoeven</surname><given-names>TV</given-names></name>, <name name-style="western"><surname>Plomer</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Seppen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ackermans</surname><given-names>MT</given-names></name>, <etal>et al</etal><article-title>Phase 1 and phase 2 drug metabolism and bile acid production of HepaRG cells in a bioartificial liver in absence of dimethyl sulfoxide</article-title>. <source>Drug Metab Dispos</source>. <year>2013</year>;<volume>41</volume>(<issue>3</issue>):<fpage>562</fpage>&#8211;<lpage>7</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1124/dmd.112.049098">10.1124/dmd.112.049098</ext-link></comment><pub-id pub-id-type="pmid">23238784</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.112.049098</pub-id></mixed-citation></ref><ref id="pone.0193664.ref027"><label>27</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Shimada</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Yamazaki</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Mimura</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Inui</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Guengerich</surname><given-names>FP</given-names></name>. <article-title>Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians</article-title>. <source>J Pharmacol Exp Ther</source>. <year>1994</year>;<volume>270</volume>(<issue>1</issue>):<fpage>414</fpage>&#8211;<lpage>23</lpage>. <pub-id pub-id-type="pmid">8035341</pub-id></mixed-citation></ref><ref id="pone.0193664.ref028"><label>28</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Evans</surname><given-names>WE</given-names></name>, <name name-style="western"><surname>Relling</surname><given-names>MV</given-names></name>. <article-title>Pharmacogenomics: translating functional genomics into rational therapeutics</article-title>. <source>Science</source>. <year>1999</year>;<volume>286</volume>(<issue>5439</issue>):<fpage>487</fpage>&#8211;<lpage>91</lpage>. <pub-id pub-id-type="pmid">10521338</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.286.5439.487</pub-id></mixed-citation></ref><ref id="pone.0193664.ref029"><label>29</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hart</surname><given-names>SN</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Nakamoto</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Wesselman</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhong</surname><given-names>XB</given-names></name>. <article-title>Genetic polymorphisms in cytochrome P450 oxidoreductase influence microsomal P450-catalyzed drug metabolism</article-title>. <source>Pharmacogenet Genomics</source>. <year>2008</year>;<volume>18</volume>(<issue>1</issue>):<fpage>11</fpage>&#8211;<lpage>24</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1097/FPC.0b013e3282f2f121">10.1097/FPC.0b013e3282f2f121</ext-link></comment><pub-id pub-id-type="pmid">18216718</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/FPC.0b013e3282f2f121</pub-id></mixed-citation></ref><ref id="pone.0193664.ref030"><label>30</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Treyer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Musch</surname><given-names>A</given-names></name>. <article-title>Hepatocyte polarity</article-title>. <source>Compr Physiol</source>. <year>2013</year>;<volume>3</volume>(<issue>1</issue>):<fpage>243</fpage>&#8211;<lpage>87</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1002/cphy.c120009">10.1002/cphy.c120009</ext-link></comment><pub-id pub-id-type="pmid">23720287</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cphy.c120009</pub-id><pub-id pub-id-type="pmcid">PMC3697931</pub-id></mixed-citation></ref><ref id="pone.0193664.ref031"><label>31</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Folmes</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Martinez-Fernandez</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Arrell</surname><given-names>DK</given-names></name>, <name name-style="western"><surname>Lindor</surname><given-names>JZ</given-names></name>, <name name-style="western"><surname>Dzeja</surname><given-names>PP</given-names></name>, <etal>et al</etal><article-title>Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming</article-title>. <source>Cell Metab</source>. <year>2011</year>;<volume>14</volume>(<issue>2</issue>):<fpage>264</fpage>&#8211;<lpage>71</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cmet.2011.06.011">10.1016/j.cmet.2011.06.011</ext-link></comment><pub-id pub-id-type="pmid">21803296</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2011.06.011</pub-id><pub-id pub-id-type="pmcid">PMC3156138</pub-id></mixed-citation></ref><ref id="pone.0193664.ref032"><label>32</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Mandal</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lindgren</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Srivastava</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>AT</given-names></name>, <name name-style="western"><surname>Banerjee</surname><given-names>U</given-names></name>. <article-title>Mitochondrial function controls proliferation and early differentiation potential of embryonic stem cells</article-title>. <source>Stem Cells</source>. <year>2011</year>;<volume>29</volume>(<issue>3</issue>):<fpage>486</fpage>&#8211;<lpage>95</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1002/stem.590">10.1002/stem.590</ext-link></comment><pub-id pub-id-type="pmid">21425411</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/stem.590</pub-id><pub-id pub-id-type="pmcid">PMC4374603</pub-id></mixed-citation></ref><ref id="pone.0193664.ref033"><label>33</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Cho</surname><given-names>YM</given-names></name>, <name name-style="western"><surname>Kwon</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Pak</surname><given-names>YK</given-names></name>, <name name-style="western"><surname>Seol</surname><given-names>HW</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>YM</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>DJ</given-names></name>, <etal>et al</etal><article-title>Dynamic changes in mitochondrial biogenesis and antioxidant enzymes during the spontaneous differentiation of human embryonic stem cells</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2006</year>;<volume>348</volume>(<issue>4</issue>):<fpage>1472</fpage>&#8211;<lpage>8</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.bbrc.2006.08.020">10.1016/j.bbrc.2006.08.020</ext-link></comment><pub-id pub-id-type="pmid">16920071</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbrc.2006.08.020</pub-id></mixed-citation></ref><ref id="pone.0193664.ref034"><label>34</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Nibourg</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Boer</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>van der Hoeven</surname><given-names>TV</given-names></name>, <name name-style="western"><surname>Ackermans</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>van Gulik</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Chamuleau</surname><given-names>RA</given-names></name>, <etal>et al</etal><article-title>Perfusion flow rate substantially contributes to the performance of the HepaRG-AMC-bioartificial liver</article-title>. <source>BiotechnolBioeng</source>. <year>2012</year>;<volume>109</volume>(<issue>12</issue>):<fpage>3182</fpage>&#8211;<lpage>8</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1002/bit.24586">10.1002/bit.24586</ext-link></comment><pub-id pub-id-type="pmid">22729831</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/bit.24586</pub-id></mixed-citation></ref><ref id="pone.0193664.ref035"><label>35</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bader</surname><given-names>A</given-names></name>, <name name-style="western"><surname>De Bartolo</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Haverich</surname><given-names>A</given-names></name>. <article-title>High level benzodiazepine and ammonia clearance by flat membrane bioreactors with porcine liver cells</article-title>. <source>J Biotechnol</source>. <year>2000</year>;<volume>81</volume>(<issue>2&#8211;3</issue>):<fpage>95</fpage>&#8211;<lpage>105</lpage>. <pub-id pub-id-type="pmid">10989168</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0168-1656(00)00233-9</pub-id></mixed-citation></ref><ref id="pone.0193664.ref036"><label>36</label><mixed-citation publication-type="journal"><name name-style="western"><surname>De Bartolo</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Jarosch-Von Schweder</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Haverich</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bader</surname><given-names>A</given-names></name>. <article-title>A novel full-scale flat membrane bioreactor utilizing porcine hepatocytes: cell viability and tissue-specific functions</article-title>. <source>Biotechnol Prog</source>. <year>2000</year>;<volume>16</volume>(<issue>1</issue>):<fpage>102</fpage>&#8211;<lpage>8</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1021/bp990128o">10.1021/bp990128o</ext-link></comment><pub-id pub-id-type="pmid">10662497</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/bp990128o</pub-id></mixed-citation></ref><ref id="pone.0193664.ref037"><label>37</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kane</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Zinner</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Yarmush</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Toner</surname><given-names>M</given-names></name>. <article-title>Liver-specific functional studies in a microfluidic array of primary mammalian hepatocytes</article-title>. <source>Anal Chem</source>. <year>2006</year>;<volume>78</volume>(<issue>13</issue>):<fpage>4291</fpage>&#8211;<lpage>8</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1021/ac051856v">10.1021/ac051856v</ext-link></comment><pub-id pub-id-type="pmid">16808435</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/ac051856v</pub-id></mixed-citation></ref><ref id="pone.0193664.ref038"><label>38</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Tilles</surname><given-names>AW</given-names></name>, <name name-style="western"><surname>Baskaran</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Roy</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Yarmush</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Toner</surname><given-names>M</given-names></name>. <article-title>Effects of oxygenation and flow on the viability and function of rat hepatocytes cocultured in a microchannel flat-plate bioreactor</article-title>. <source>Biotechnol Bioeng</source>. <year>2001</year>;<volume>73</volume>(<issue>5</issue>):<fpage>379</fpage>&#8211;<lpage>89</lpage>. <pub-id pub-id-type="pmid">11320508</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/bit.1071</pub-id></mixed-citation></ref><ref id="pone.0193664.ref039"><label>39</label><mixed-citation publication-type="journal"><name name-style="western"><surname>van Wenum</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Adam</surname><given-names>AAA</given-names></name>, <name name-style="western"><surname>van der Mark</surname><given-names>VA</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Wildenberg</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Hendriks</surname><given-names>EJ</given-names></name>, <etal>et al</etal><article-title>Oxygen drives hepatocyte differentiation and phenotype stability in liver cell lines</article-title>. <source>J Cell Commun Signal</source>. <year>2018</year><comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1007/s12079-018-0456-4">10.1007/s12079-018-0456-4</ext-link></comment><pub-id pub-id-type="pmid">29399736</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12079-018-0456-4</pub-id><pub-id pub-id-type="pmcid">PMC6039343</pub-id></mixed-citation></ref><ref id="pone.0193664.ref040"><label>40</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hoeke</surname><given-names>MO</given-names></name>, <name name-style="western"><surname>Heegsma</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hoekstra</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Moshage</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Faber</surname><given-names>KN</given-names></name>. <article-title>Human FXR regulates SHP expression through direct binding to an LRH-1 binding site, independent of an IR-1 and LRH-1</article-title>. <source>PLoS One</source>. <year>2014</year>;<volume>9</volume>(<issue>2</issue>):<fpage>e88011</fpage><comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0088011">10.1371/journal.pone.0088011</ext-link></comment><pub-id pub-id-type="pmid">24498423</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0088011</pub-id><pub-id pub-id-type="pmcid">PMC3912179</pub-id></mixed-citation></ref><ref id="pone.0193664.ref041"><label>41</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Godoy</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Schmidt-Heck</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Natarajan</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Lucendo-Villarin</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Szkolnicka</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Asplund</surname><given-names>A</given-names></name>, <etal>et al</etal><article-title>Gene networks and transcription factor motifs defining the differentiation of stem cells into hepatocyte-like cells</article-title>. <source>J Hepatol</source>. <year>2015</year>;<volume>63</volume>(<issue>4</issue>):<fpage>934</fpage>&#8211;<lpage>42</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jhep.2015.05.013">10.1016/j.jhep.2015.05.013</ext-link></comment><pub-id pub-id-type="pmid">26022688</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jhep.2015.05.013</pub-id><pub-id pub-id-type="pmcid">PMC4580233</pub-id></mixed-citation></ref><ref id="pone.0193664.ref042"><label>42</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Schrem</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Klempnauer</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Borlak</surname><given-names>J</given-names></name>. <article-title>Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression</article-title>. <source>Pharmacol Rev</source>. <year>2002</year>;<volume>54</volume>(<issue>1</issue>):<fpage>129</fpage>&#8211;<lpage>58</lpage>. <pub-id pub-id-type="pmid">11870262</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/pr.54.1.129</pub-id></mixed-citation></ref><ref id="pone.0193664.ref043"><label>43</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Schrem</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Klempnauer</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Borlak</surname><given-names>J</given-names></name>. <article-title>Liver-enriched transcription factors in liver function and development. Part II: the C/EBPs and D site-binding protein in cell cycle control, carcinogenesis, circadian gene regulation, liver regeneration, apoptosis, and liver-specific gene regulation</article-title>. <source>Pharmacol Rev</source>. <year>2004</year>;<volume>56</volume>(<issue>2</issue>):<fpage>291</fpage>&#8211;<lpage>330</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1124/pr.56.2.5">10.1124/pr.56.2.5</ext-link></comment><pub-id pub-id-type="pmid">15169930</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/pr.56.2.5</pub-id></mixed-citation></ref><ref id="pone.0193664.ref044"><label>44</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Iacob</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Rudrich</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Rothe</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kirsch</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Maasoumy</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Narain</surname><given-names>N</given-names></name>, <etal>et al</etal><article-title>Induction of a mature hepatocyte phenotype in adult liver derived progenitor cells by ectopic expression of transcription factors</article-title>. <source>Stem Cell Res</source>. <year>2011</year>;<volume>6</volume>(<issue>3</issue>):<fpage>251</fpage>&#8211;<lpage>61</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.scr.2011.02.002">10.1016/j.scr.2011.02.002</ext-link></comment><pub-id pub-id-type="pmid">21474405</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.scr.2011.02.002</pub-id></mixed-citation></ref><ref id="pone.0193664.ref045"><label>45</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Chiang</surname><given-names>JY</given-names></name>. <article-title>Bile acids: regulation of synthesis</article-title>. <source>J Lipid Res</source>. <year>2009</year>;<volume>50</volume>(<issue>10</issue>):<fpage>1955</fpage>&#8211;<lpage>66</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1194/jlr.R900010-JLR200">10.1194/jlr.R900010-JLR200</ext-link></comment> ; PubMed Central PMCID: PMCPMC2739756.<pub-id pub-id-type="pmid">19346330</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1194/jlr.R900010-JLR200</pub-id><pub-id pub-id-type="pmcid">PMC2739756</pub-id></mixed-citation></ref><ref id="pone.0193664.ref046"><label>46</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Gissen</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Arias</surname><given-names>IM</given-names></name>. <article-title>Structural and functional hepatocyte polarity and liver disease</article-title>. <source>J Hepatol</source>. <year>2015</year>;<volume>63</volume>(<issue>4</issue>):<fpage>1023</fpage>&#8211;<lpage>37</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jhep.2015.06.015">10.1016/j.jhep.2015.06.015</ext-link></comment><pub-id pub-id-type="pmid">26116792</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jhep.2015.06.015</pub-id><pub-id pub-id-type="pmcid">PMC4582071</pub-id></mixed-citation></ref><ref id="pone.0193664.ref047"><label>47</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bachour-El Azzi</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Sharanek</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Burban</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Guevel</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Abdel-Razzak</surname><given-names>Z</given-names></name>, <etal>et al</etal><article-title>Comparative Localization and Functional Activity of the Main Hepatobiliary Transporters in HepaRG Cells and Primary Human Hepatocytes</article-title>. <source>Toxicol Sci</source>. <year>2015</year>;<volume>145</volume>(<issue>1</issue>):<fpage>157</fpage>&#8211;<lpage>68</lpage>. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1093/toxsci/kfv041">10.1093/toxsci/kfv041</ext-link></comment><pub-id pub-id-type="pmid">25690737</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/kfv041</pub-id><pub-id pub-id-type="pmcid">PMC4833040</pub-id></mixed-citation></ref><ref id="pone.0193664.ref048"><label>48</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hoekstra</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Deurholt</surname><given-names>T</given-names></name>, <name name-style="western"><surname>ten Bloemendaal</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Desille</surname><given-names>M</given-names></name>, <name name-style="western"><surname>van Wijk</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Clement</surname><given-names>B</given-names></name>, <etal>et al</etal><article-title>Assessment of in vitro applicability of reversibly immortalized NKNT-3 cells and clonal derivatives</article-title>. <source>Cell Transplant</source>. <year>2006</year>;<volume>15</volume>(<issue>5</issue>):<fpage>423</fpage>&#8211;<lpage>33</lpage>.<pub-id pub-id-type="pmid">16970284</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>